Recent pharmaceutical cases in regulatory and intellectual property law have resulted in developments on several fronts, including:
- regulatory matters;
- patent validity and damages;
- Patented Medicines (Notice of Compliance) Regulations proceedings; and
- class actions.
In this paper, we review some of
